Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Bruce L who wrote (3596)	1/11/2000 4:19:00 PM
From: Jacques Chitte	Read Replies (1) \| Respond to of 4140

Why didn't Lehman delay the private placement until after the panel? I can understand that perhaps there is a time factor involved here, but wouldn't Sunrise get a better deal post-approval? Where's the hole in my thinking?

To: Bruce L who wrote (3596)	1/11/2000 4:31:00 PM
From: Trebor	Read Replies (1) \| Respond to of 4140

FWIW, SNRS is paying an incredible premium for those who fool around, as I do, with covered calls. As of today's close, you could sell the January $10 for $3.50 or the January $12.50 for $2.375. Assuming you sold the Jan. $10 and were called out, that would be a 27% return. Assuming you sold the Jan. $12.50 and were called out, it would be a 40% return. Not too shabby for an 11-day investment (Jan. options expire Jan. 21). This is one of the richest premiums I've ever seen for a covered call play. Of course the risk is that the stock will collapse between now and then.